Abstract
Severe mental illness (SMI) is associated with increased risk for type 2 diabetes, partly due to adverse metabolic effects of antipsychotic medications. In public health care settings, annual screening rates are 30%. We measured adherence to national diabetes screening guidelines for patients taking antipsychotic medications. To estimate diabetes screening prevalence among patients with SMI within an integrated health care system, and to assess characteristics associated with lack of screening. Retrospective cohort study. Antipsychotic-treated adults with SMI. We excluded participants with known diabetes. Primary outcome was screening via fasting glucose test or hemoglobin A1c during a 1-year period. In 2014, 16,754 patients with SMI diagnoses were receiving antipsychotics. Seventy-four percent of these patients' providers ordered diabetes screening tests that year, but only 55% (9247/16,754) received screening. When the observation time frame was extended to 2 years, 73% (12,250/16,754) were screened. Adjusting for sex and race/ethnicity, young adults (aged 18-29 years) were less likely to receive screening than older age groups [adjusted RR (aRR) 1.23-1.57, p < 0.0001]. Compared to whites, screening was more common for Asians...Continue Reading
References
Jan 1, 1997·Journal of Clinical Epidemiology·J F Steiner, A V Prochazka
Jan 6, 2000·Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality·K A Hiltunen
Feb 5, 2000·JAMA : the Journal of the American Medical Association·B G DrussH M Krumholz
Aug 28, 2001·Diabetes Care·S G WannametheeUNKNOWN British Regional Heart Study
Jan 30, 2004·Diabetes Care·UNKNOWN American Diabetes AssociationUNKNOWN North American Association for the Study of Obesity
Apr 27, 2007·Journal of the American Medical Informatics Association : JAMIA·Joan S AshRichard H Dykstra
Jun 30, 2007·American Journal of Public Health·Andrew J KarterSusan L Ettner
Mar 29, 2008·Health Services Research·Linda Simoni-WastilaBruce Stuart
Sep 27, 2008·BMC Psychiatry·David P J OsbornIrwin Nazareth
Jan 13, 2009·General Hospital Psychiatry·Seth HimelhochLisa Dixon
Oct 29, 2009·JAMA : the Journal of the American Medical Association·Christoph U CorrellAnil K Malhotra
Dec 3, 2009·Psychiatric Services : a Journal of the American Psychiatric Association·Susan M EssockMolly T Finnerty
Dec 19, 2009·Schizophrenia Bulletin·Deanna L KellyLisa Dixon
Jan 6, 2010·Archives of General Psychiatry·Elaine H MorratoJohn W Newcomer
Dec 13, 2012·Schizophrenia Research·S G ParameswaranC V Mangurian
Feb 2, 2013·American Journal of Epidemiology·Daniel Westreich, Sander Greenland
Jun 4, 2013·Psychiatric Services : a Journal of the American Psychiatric Association·Christina MangurianDean Schillinger
Aug 24, 2013·JAMA Psychiatry·William V BoboWayne A Ray
Aug 31, 2013·JAMA : the Journal of the American Medical Association·Marc G JaffeAlan S Go
Oct 17, 2014·JAMA Psychiatry·Christoph U CorrellJohn M Kane
Jan 3, 2015·International Review of Psychiatry·Silke A von Esenwein, Benjamin G Druss
Jan 13, 2015·General Hospital Psychiatry·John Q YoungConstance Weisner
Nov 10, 2015·JAMA Internal Medicine·Christina MangurianDean Schillinger
Jan 6, 2017·BMJ : British Medical Journal·Eleanor BarryTrisha Greenhalgh
Citations
Jun 15, 2018·Diabetes Care·Christina V MangurianJulie A Schmittdiel
Nov 11, 2019·Journal of General Internal Medicine·Christina MangurianJulie Schmittdiel
Aug 24, 2020·The Psychiatric Quarterly·Maria E GarciaChristina Mangurian
Sep 11, 2019·European Psychiatry : the Journal of the Association of European Psychiatrists·Marina GarrigaMerete Osler
Jul 31, 2020·BMC Family Practice·Kirsti M JakobsMarion J C Biermans
Nov 1, 2020·Nature Reviews. Cardiology·René Ernst NielsenSvend Eggert Jensen
Jan 20, 2021·BMC Health Services Research·Erica L StockbridgeKarabi Nandy
Apr 8, 2021·Advances in Therapy·Miquel BernardoRicardo Gómez-Huelgas
Aug 26, 2021·Journal of Psychosocial Nursing and Mental Health Services·Mary C CrangCheryl Schraeder